AstraZeneca To Pay $425 Mn For Settling Nexium, Prilosec Litigation In US
British drugmaker AstraZeneca on Tuesday said it will pay USD 425 million to settle product liability litigations against prescription-only acid-reflux medicine Nexium and heartburn drug Prilosec in the United States.
The agreements effectively resolve all pending claiAs
_20240724175817_original_image_20.webp)
